Next Article in Journal
Cancer Biomarkers: Are We Ready for the Prime Time?
Next Article in Special Issue
Automated Dermoscopy Image Analysis of Pigmented Skin Lesions
Previous Article in Journal
Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
Previous Article in Special Issue
Angiogenesis and Melanoma

Biology of Human Cutaneous Melanoma

Maryland Melanoma Center, Weinberg Cancer Institute, Franklin Square Hospital Center, Baltimore, MD, USA
Author to whom correspondence should be addressed.
Cancers 2010, 2(1), 165-189;
Received: 28 January 2010 / Revised: 4 March 2010 / Accepted: 9 March 2010 / Published: 12 March 2010
(This article belongs to the Special Issue Current Concepts in the Diagnosis and Treatment of Cutaneous Melanoma)
A review of the natural behavior of cutaneous melanoma, clinical and pathological factors, prognostic indicators, some basic research and the present and possible futuristic strategies in the management of this disease are presented. While surgery remains to be the most effective therapeutic approach in the management of early primary lesions, there is no standard adjuvant therapy after surgical resection, or for metastatic disease. View Full-Text
Keywords: biology; cutaneous; melanoma; therapeutic approaches biology; cutaneous; melanoma; therapeutic approaches
Show Figures

Figure 1

MDPI and ACS Style

Elias, E.G.; Hasskamp, J.H.; Sharma, B.K. Biology of Human Cutaneous Melanoma. Cancers 2010, 2, 165-189.

AMA Style

Elias EG, Hasskamp JH, Sharma BK. Biology of Human Cutaneous Melanoma. Cancers. 2010; 2(1):165-189.

Chicago/Turabian Style

Elias, Elias G., Joanne H. Hasskamp, and Bhuvnesh K. Sharma 2010. "Biology of Human Cutaneous Melanoma" Cancers 2, no. 1: 165-189.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop